M7824 in Subjects With HPV Associated Malignancies
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs MSB 0011359C (Primary)
- Indications Anal cancer; Cervical cancer; Human papillomavirus infections; Neuroendocrine carcinoma; Oropharyngeal cancer; Penile cancer; Rectal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 22 Feb 2018 Status changed from not yet recruiting to recruiting.
- 17 Feb 2018 Planned initiation date changed from 14 Feb 2018 to 23 Feb 2018.
- 12 Feb 2018 New trial record